2nd Annual MarketsandMarkets Next Gen Immuno-Oncology Congress
Location: Hilton Garden Inn Philadelphia Center City Dates: Sept. 19-20, 2019 Booth: #Ex-7 Presentation Title: Accelerating Therapeutic Antibody Discovery and Development with Innovative Humanized Mouse…
Read more
Biocytogen Closes $79M Series D Funding
On August 2019, Beijing Biocytogen Co., Ltd. ("Biocytogen") announced the closing of its Series D funding of $79M (RMB 543M). This round of financing was…
Read more
Biocytogen’s President & CEO, Dr. Yuelei Shen, Speaks at Harvard China Forum at Harvard University
Harvard College China Forum, an annual Harvard tradition for 22 years, welcomed and opened to 1,200 domestic and international participants and over 100 domestic and…
Read more
Biocytogen’s Integrated One-stop Preclinical Services and the RenMab Mouse Shine at AACR 2019
American Association for Cancer Research (AACR) Annual Meeting 2019 was held in Atlanta, Georgia from March 29 to April 3, 2019, with a theme of “Integrative…
Read more
Former Swedish Prime Minister Visits Biocytogen
Former Swedish Prime Minister, former president of the European Council Mr. Fredrik Reinfeldt and Executive Chairman of Nordic Growth Technology (NGT) Partners, professor Niclas Adler…
Read more
Immuno-Oncology (IO) Summit 2018
Biocytogen attended Immuno-Oncology (IO) Summit 2018 congress in Boston, MA, Aug 28 - Aug 31. IO Summit has become the leading annual meeting focusing on…
Read more
Biocytogen showcases innovative gene-editing strategies at Experimental Biolo
BiocytogenTM Gene Targeting Services participated at the Experimental Biology (EB) 2018 meeting in San Diego, CA, April 22-24. This conference was comprised of more than…
Read more